Gilead 337-1746 ¿A Phase 3b, Multicenter, Open-Label Study to Investigate the Efficacy and Safety of Ledipasvir/Sofosbuvir, With or Without Ribavirin, in HCV Infected Subjects Who Have Failed Prior Treatment With Sofosbuvir-based Therapies
Clinical Trial Grant
Administered By
Medicine, Gastroenterology
Awarded By
Gilead Sciences, Inc.
Start Date
October 1, 2015
End Date
September 30, 2018
Administered By
Medicine, Gastroenterology
Awarded By
Gilead Sciences, Inc.
Start Date
October 1, 2015
End Date
September 30, 2018